Actively Recruiting
Comparing Adaptive and Conventional Deep Brain Stimulation for Levodopa-Responsive Parkinsons Disease Using the AlphaDBS System
Led by Newronika · Updated on 2026-09-24
104
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of adaptive deep brain stimulation aDBS compared to conventional deep brain stimulation cDBS using the AlphaDBS system in people with levodopa-responsive Parkinsons disease. This prospective, multi-center, randomized, double-blind, crossover trial aims to first confirm the safety and effectiveness of cDBS, then directly compare aDBS to cDBS. Previous European studies suggest aDBS might increase ON-time without troublesome dyskinesias for some patients. Participants will be randomly assigned to receive either aDBS or cDBS Mode 1 for three months, then switch to the other mode Mode 2 for another three months. After completing both modes, subjects will choose their preferred mode to continue for an additional three months. Throughout the study, participants will use the AlphaDBS system, and patient diaries will be completed at various time points to monitor symptoms. Participants will attend multiple visits for assessment of Parkinsons disease symptoms and treatment effects. Researchers will measure improvement in Good On Time GOT after three months of cDBS compared with baseline, as well as differences between aDBS and cDBS after six months. Other measures include motor function scales and quality of life assessments. Participants preferences for the stimulation modes will also be recorded, and safety will be monitored during the trial, which may last up to three years.
CONDITIONS
Brief Title
Investigating Adaptive Deep Brain Stimulation in Parkinson's Disease Management
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here